The implanting clinician stated the patient was experiencing a superficial infection and prescribed antibiotics (name, dose, and duration are unknown).On october 20, 2020, the clinical representative followed up with the patient on the condition status.The patient stated the pustule was gone and reported feeling well.The clinical representative confirmed that the implant procedure was performed in a sterile environment with sterile field handling protocols, sterile barriers of all products used were intact before the implant, and the procedure was completed following the product instructions for us.Through a review of sterilization and packaging records for the respective product lots, stimwave has confirmed that the product was delivered sterile, no trend of infection is evident for lots swo200730 and swo200727, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.Based on this information, the infection was confirmed/replicated.There is no evidence that the product did not meet specifications, and the stimulator is used to treat pain.The cause of the infection is unknown/no problem found.
|
On october 19, 2020, the patient-reported skin itchiness and pus coming out of the needle entry site.On the same date, the patient followed-up on the condition with the implanting clinician.
|